Link to publication Citation for published version (APA): Dimitrijevic, I., Malmsjö, M., Andersson, C., Rissler, P., & Edvinsson, L. (2009). Increased angiotensin II type 1 receptor expression in temporal arteries from patients with giant cell arteritis. Ophthalmology, 116(5), 990-996. DOI: 10.1016990-996. DOI: 10. /j.ophtha.2008 General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.• You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal
___________________________________________ LUP
Lund University PublicationsInstitutional Repository of Lund University __________________________________________________ This is an author produced version of a paper published inOphthalmology. This paper has been peer-reviewed but does not include the final publisher proof-corrections or journal pagination.Citation for the published paper: Angiotensin II is a vasoactive peptide involved in vessel inflammation during atherosclerosis, and angiotensin II receptor inhibitors are effective in preventing atherosclerosis. The present study was performed to elucidate the role of angiotensin type 1 (AT 1 ) and type 2 (AT 2 ) receptors in GCA.
ParticipantsTen patients with GCA and ten control patients, who were clinically suspected of having GCA but were diagnosed as not having GCA, were included.
MethodsImmunohistochemistry, using anti-AT 1 and anti-AT 2 antibodies, was performed on formalinfixed and paraffin-embedded temporal arteries.
Main outcome measuresAT 1 and AT 2 receptor immunostaining intensity was quantified.
ResultsHematoxylin-eosin-stained sections of temporal arteries from patients with GCA showed intimal hyperplasia, internal elastic lamina degeneration and band-shaped infiltrates of inflammatory cells, including lymphocytes, histocytes, and multinucleated giant cells. AT 1 3 receptor staining was primarily observed in the medial layer of the temporal arteries, and was higher in the patients with GCA than in the control patients. This was a result of increased AT 1 receptor immunostaining of both vascular smooth muscle cells and of infiltrating inflammatory cells. Only faint immunostaining was seen for AT 2 receptors, primarily in the endothelial cells, and to a lesser extent on the smooth muscle cells. Immunostaining with antibodies for the AT 2 receptor was similar in the patients with GCA and in controls.
ConclusionsThese results suggest that AT 1 receptors play a role in the development of GCA. Inhibition of the angiotensin system may thus provide a non-corticosteroid alternative for the treatment of GCA.4